Thank you very much, Mr. Chair. I appreciate those extra 30 seconds.
Thanks to our witnesses for being here. I appreciate all your kind comments with respect to getting back to business in committee and in the House.
I would like to start with the Canadian Chamber of Commerce. Mr. Brakel, I'd like to pick up on the innovation box a little bit. If I heard you right—I won't put words in your mouth—I think you said “in lieu of” the SR and ED. I guess I just want to push down on that a little bit more.
We heard from our witnesses yesterday that there are different ways that this innovation box has actually been implemented in different countries. It's simply a matter of one way versus another. When I look at a small business, they might do a lot of patent work with respect to a process within their business, and that doesn't lend itself well to a product that they're actually selling. With that in mind, they would never be able to take advantage of this if you took out the SR and ED completely. So I'd be concerned that you'd say “in lieu of”, because that would completely eliminate that away from them.
How have other countries been successful in implementing it? If you're going to pursue this, it seems to me that it would take a little bit of time to figure out how to implement it, and to implement it properly.